Back to search

National and Kapodistrian University of Athens

Μελέτη της μοριακής βάσης της (υποκλινικής) αντοχής στις κινολόνες σε κλινικά στελέχη E. Coli

Abstract

dc:description

The urinary tract infections are very common in humans and E. coli is the principal causative microorganism. Fluoroquinolones are antibiotics with excellent activity against E. coli. Intensive use of quinolones in the treatment of common infections in humans and animals has led to the spread of resistant microorganisms. One hundred and seventy E. coli strains were collected consecutively (March to December 2000) from UTI outpatients at Laikon teaching hospital and a Center of Primary Health in Athens. Patients admitted to a hospital during the previous month were excluded. Patient data, including demographics, underlying disease, immunological status, hospitalisations, invasive device use, and use of antibiotics during the last 12 months, were also obtained. Species identification was confirmed with the API 20E System (BioMerieux). MICs to nalidixic acid and ciprofloxacin were determined by the E-test method (AB Biodisk). Susceptibility to other antimicrobials was determined by the disk diffusion method. PCR amplification of the quinolone resistance determining regions (QRDRs) of the gyrA and parC genes was performed as described previously. Amplicons were purified with a QiaQuick spin PCR purification kit and the nucleotide sequences were determined using an automatic sequencer (ABI Prisma, Applied Biosystems). Associations between QREC isolation and various patient characteristics were assessed by contingency tables and chi-square tests with continuity corrections. Relative risks were estimated by calculating odds ratios and their corresponding 95% confidence intervals through backward multiple logistic regression analysis using Stata 6 software (Stata Corp., College Station, TX, USA). Resistance to nalidixic acid was observed in 25 (14.7%) isolates, 15 (60%) of which were also resistant to ciprofloxacin. An association of resistance to quinolones with resistance to other antibiotics was evident as in the whole sample described above. Mutations in the QRDR of the gyrA gene were detected in all 25 isolates. Additional mutations in the QRDR of the parC gene were found in 15 of the QREC isolates. The most frequent mutations were those leading to the following substitutions: Leu for Ser-83 of gyrA (22 isolates), Asn for Asp-87 of gyrA (15 isolates), and lie for Ser-80 of parC (14 isolates). High-level resistance to ciprofloxacin was associated with mutations at both 83 and 87 codons of the gyrA gene and one or two additional mutations in parC (codons 80 and 84). Univariate analysis showed that isolation of QREC strains was positively associated with age. Older (>65 years) UTI patients were at increased risk of being infected by a QREC than a quinolone-susceptible strain as compared with younger patients (P = 0.01). Isolation of QREC strains was also related strongly with the presence of underlying chronic diseases (P < 0.001), complicated UTIs (P = 0.005), previous UTI episodes (P < 0.001), and recent exposure to quinolones (P < 0.001). Associations of QREC isolation with gender, and use of non-quinolone antibiotics were not statistically significant. Multivariate logistic regression analysis indicated that, only chronic disease (odds ratio [OR] 22.3, 95% confidence interval [Cl] 3-128, P = 0.03) and use of fluoroquinolones (OR 80.7, CI 11-613, P < 0.001) acted as independent risk factors for infection by a strain in this population. Resistance was the result of quinolones use, because all but two patients had used quinolones during the last 12 months. Chronic disease, which acted as the second independent risk factor, probably reflects the use of antibiotics before the beginning of this study. And the multiple resistance of QREC strains reflects the need of antibiotic use by patients with chronic diseases. The use of quinolones causes the first mutation and when quinolones are used again, second step mutations develop high-level resistance. As result of this study quinolone resistance is increasing in our country. They are very effective drugs against UTIs. But we must control the use of these antibiotics in order to reduce the development of such resistance.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chaniotaki, Sofia
  • Χανιωτάκη, Σοφία

Subjects

dc:subject × 11

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20495

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chaniotaki, Sofia; Χανιωτάκη, Σοφία. Μελέτη της μοριακής βάσης της (υποκλινικής) αντοχής στις κινολόνες σε κλινικά στελέχη E. Coli. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/20495